Primary Site >> Pancreatic Cancer
Gene >> C3
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|
|
Ref: Local secretion of complement C3 in the exocrine pancreas: ductal epithelial cells as a possible biosynthetic site. PMID: 8964419 |
Ref: Frequent expression of complement resistance factors CD46, CD55, and CD59 on gastrointestinal cancer cells limits the therapeutic potential of monoclonal antibody 17-1A. PMID: 9121154 |
Ref: Transforming growth factor-beta1 acts as a potent inhibitor of complement C3 biosynthesis in human pancreatic cancer cell lines. PMID: 10707928 |
Ref: Functionalized S-thio-di- and S-oligosaccharide precursors as templates for novel SLex/a mimetic antimetastatic agents. PMID: 12678821 |
Ref: [Analysis of pancreatic cancer peripheral blood by comparative proteomics]. PMID: 23578431 Ref: An intensified systemic trafficking of bone marrow-derived stem/progenitor cells in patients with pancreatic cancer. PMID: 23672538 Ref: Profiling the potential tumor markers of pancreatic ductal adenocarcinoma using 2D-DIGE and MALDI-TOF-MS: up-regulation of Complement C3 and alpha-2-HS-glycoprotein. PMID: 23719603 Ref: Expression and clinical significance of complement C3, complement C4b1 and apolipoprotein E in pancreatic cancer. PMID: 23946775 Ref: Synthesis of N-acetyl Glucosamine Analogs as Inhibitors for Hyaluronan Biosynthesis. PMID: 27099411 |
Ref: Bile proteomics for differentiation of malignant from benign biliary strictures: a pilot study. PMID: 25304323 |
Ref: Evaluating hepatocellular carcinoma cell lines for tumour samples using within-sample relative expression orderings of genes. PMID: 28481424 |
Ref: Structural characterization of a galactan from Ophiopogon japonicus and anti-pancreatic cancer activity of its acetylated derivative. PMID: 29518447 Ref: Ancistroyafungines A-D, 5,8'- and 5,1'-coupled naphthylisoquinoline alkaloids from a Congolese Ancistrocladus species, with antiausterity activities against human PANC-1 pancreatic cancer cells. PMID: 30059720 |